Scatter Photocoagulation Does Not Reduce Macular Edema or Treatment Burden in Patients with Retinal Vein Occlusion: The RELATE Trial

Ophthalmology

Volumn 122, Issue 7, 2015, Pages 1426-1437

  Campochiaro, Peter A ^a   Hafiz, Gulnar ^a   Mir, Tahreem A ^a   Scott, Adrienne W ^a   Solomon, Sharon ^a   Zimmer Galler, Ingrid ^a   Sodhi, Akrit ^a   Duh, Elia ^a   Ying, Howard ^a   Wenick, Adam ^a   Shah, Syed Mahmood ^a   Do, Diana V ^a   Nguyen, Quan D ^a   Kherani, Saleema ^a   Sophie, Raafay ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGED; ARTICLE; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; FEMALE; HUMAN; LASER COAGULATION; MACULAR EDEMA; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINAL THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TREATMENT DURATION; VISUAL ACUITY; ANTAGONISTS AND INHIBITORS; DOUBLE BLIND PROCEDURE; INTRAVITREAL DRUG ADMINISTRATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OPTICAL COHERENCE TOMOGRAPHY; PHYSIOLOGY; RETINAL VEIN OCCLUSION;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84937732875     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2015.04.006     Document Type: Article

References (22)

1. P.A. Campochiaro, G. Hafiz, S.M. Shah, and et al. Ranibizumab for macular edema due to retinal vein occlusions; implication of VEGF as a critical stimulator Molec Ther 16 2008 791 799
2. P.A. Campochiaro, J.S. Heier, L. Feiner, and et al. Ranibizumab for macular edema following branch retinal vein occlusion: 6-month primary endpoint results of a phase III study Ophthalmology 117 2010 1102 1112
3. D.M. Brown, P.A. Campochiaro, R.P. Singh, and et al. Efficacy and safety of ranibizumab in the treatment of macular edema secondary to central retinal vein occlusion: 6-month results of the phase III CRUISE study Ophthalmology 117 2010 1124 1133
4. P.J. Rosenfeld, D.M. Brown, J.S. Heier, and et al. Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 2006 1419 1431
5. D.M. Brown, P.K. Kaiser, M. Michels, and et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444
6. Q.D. Nguyen, S. Tatlipinar, S.M. Shah, and et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema Am J Ophthalmol 142 2006 961 969
7. Q.D. Nguyen, S.M. Shah, J.S. Heier, and et al. Primary end point (6 months) results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) study Ophthalmology 116 2009 2175 2181
8. Q.D. Nguyen, D.M. Brown, D.M. Marcus, and et al. Ranibizumab for diabetic macular edema. Results from 2 phase III randomized trials: RISE and RIDE Ophthalmology 119 2012 789 801
9. D. Boyer, J. Heier, D.M. Brown, and et al. Vascular endothelial growth factor trap-eye for macular edema secondary to central retinal vein occlusion. Six-month results of the phase 3 COPERNICUS study Ophthalmology 119 2012 1024 1032
10. F.G. Holz, J. Roider, Y. Ogura, and et al. VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study Br J Ophthalmol 97 2014 278 284
11. P.A. Campochiaro, W.L. Clark, D.S. Boyer, and et al. Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study Ophthalmology 122 2015 538 544
12. J.S. Heier, P.A. Campochiaro, L. Yau, and et al. Ranibizumab for macular edema due to retinal vein occlusions: long term follow-up in the HORIZON trial Ophthalmology 119 2012 802 809
13. P.A. Campochiaro, G. Hafiz, R. Channa, and et al. Antagonism of vascular endothelial growth factor for macular edema caused by retinal vein occlusion: two-year outcomes Ophthalmology 117 2010 2387 2394
14. P.A. Campochiaro, R. Sophie, J. Pearlman, and et al. Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study Ophthalmology 121 2014 209 219
15. P.A. Campochiaro, R.B. Bhistikul, H. Shapiro, and R.G. Rubio Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion Ophthalmology 120 2013 795 802
16. R. Sophie, G. Hafiz, A. Scott, and et al. Long term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusion Am J Ophthalmol 156 2013 693 705
17. The Early Treatment Diabetic Retinopathy Study Group Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1 Arch Ophthalmol 103 1985 1796 1806
18. B.G. Busbee, A.C. Ho, D.M. Brown, and et al. Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration Ophthalmology 120 2013 1046 1056
19. A.C. Ho, B.G. Busbee, C.D. Regillo, and et al. Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration Ophthalmology 121 2014 2181 2192
20. P.A. Campochiaro, D.F. Choy, D.V. Do, and et al. Monitoring ocular drug therapy by analysis of aqueous samples Ophthalmology 116 2009 2158 2164
21. R.F. Spaide Prospective study of peripheral panretinal photocoagulation of areas of nonperfusion in central retinal vein occlusion Retina 33 2013 56 62
22. M. Rehak, E. Tilgner, A. Franke, and et al. Early peripheral laser photocoagulation of nonperfused retina improves vision in patients with central retinal vein occlusion (results of a proof of concept study) Graefes Arch Clin Exp Ophtalmol 252 2014 745 752